Align Technology Inc (ALGN) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Align Technology Inc (ALGN) has a cash flow conversion efficiency ratio of 0.036x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($151.04 Million) by net assets ($4.15 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Align Technology Inc (ALGN) defensive interval to measure how many days the company can operate on defensive assets alone.
Align Technology Inc - Cash Flow Conversion Efficiency Trend (1999–2025)
This chart illustrates how Align Technology Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Align Technology Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Align Technology Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kakao Corp
KO:035720
|
0.021x |
|
Carrefour SA
PA:CA
|
0.366x |
|
Toromont Industries Ltd.
TO:TIH
|
0.038x |
|
DWS Group GmbH & Co. KGaA
XETRA:DWS
|
0.033x |
|
Industrivarden AB ser. C
ST:INDU-C
|
0.000x |
|
BUREAU VERITAS ADR EO-12
F:4BV0
|
N/A |
|
Renaissancere Holdings Ltd
NYSE:RNR
|
0.037x |
|
Haohua Chemical Science & Technology Corp Ltd
SHG:600378
|
0.029x |
Annual Cash Flow Conversion Efficiency for Align Technology Inc (1999–2025)
The table below shows the annual cash flow conversion efficiency of Align Technology Inc from 1999 to 2025. For the full company profile with market capitalisation and key ratios, see Align Technology Inc market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $4.05 Billion | $593.22 Million | 0.147x | -23.56% |
| 2024-12-31 | $3.85 Billion | $738.23 Million | 0.192x | -11.45% |
| 2023-12-31 | $3.63 Billion | $785.78 Million | 0.216x | +37.05% |
| 2022-12-31 | $3.60 Billion | $568.73 Million | 0.158x | -51.21% |
| 2021-12-31 | $3.62 Billion | $1.17 Billion | 0.324x | +58.07% |
| 2020-12-31 | $3.23 Billion | $662.17 Million | 0.205x | -63.11% |
| 2019-12-31 | $1.35 Billion | $747.27 Million | 0.555x | +25.39% |
| 2018-12-31 | $1.25 Billion | $554.68 Million | 0.443x | +16.13% |
| 2017-12-31 | $1.15 Billion | $438.54 Million | 0.381x | +53.22% |
| 2016-12-31 | $995.39 Million | $247.65 Million | 0.249x | -11.36% |
| 2015-12-31 | $847.93 Million | $238.00 Million | 0.281x | -6.88% |
| 2014-12-31 | $752.77 Million | $226.90 Million | 0.301x | +2.75% |
| 2013-12-31 | $633.97 Million | $185.98 Million | 0.293x | +27.47% |
| 2012-12-31 | $581.32 Million | $133.78 Million | 0.230x | -13.43% |
| 2011-12-31 | $490.78 Million | $130.47 Million | 0.266x | -22.47% |
| 2010-12-31 | $377.75 Million | $129.53 Million | 0.343x | +26.24% |
| 2009-12-31 | $273.04 Million | $74.17 Million | 0.272x | +49.35% |
| 2008-12-31 | $218.54 Million | $39.75 Million | 0.182x | -44.47% |
| 2007-12-31 | $161.15 Million | $52.78 Million | 0.327x | +295.04% |
| 2006-12-31 | $83.56 Million | $-14.03 Million | -0.168x | -197.52% |
| 2005-12-31 | $93.44 Million | $16.09 Million | 0.172x | -39.90% |
| 2004-12-31 | $85.74 Million | $24.56 Million | 0.286x | +48.83% |
| 2003-12-31 | $62.98 Million | $12.12 Million | 0.192x | +133.65% |
| 2002-12-31 | $70.62 Million | $-40.40 Million | -0.572x | +26.96% |
| 2001-12-31 | $99.40 Million | $-77.86 Million | -0.783x | -212.79% |
| 2000-12-31 | $-84.67 Million | $-58.80 Million | 0.694x | +15.89% |
| 1999-12-31 | $-19.41 Million | $-11.63 Million | 0.599x | -- |
About Align Technology Inc
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisali… Read more